Crene Biotechnology,API,pharmaceutical intermediates,small molecules,prostaglandins,chemicals

+ AII PRODUCTS

- Prostaglandins - Custom Synthesis - PARP Inhibitors - PI3K Inhibitors - FAK Inhibitors - AKT Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - c-Met Inhibitors - CDK Inhibitors - CYP17 Inhibitors - DNA/RNA Inhibitors - mTOR Inhibitors - SRC Inhibitors - Others - Veterinary APIs

Catalog No	CAS NO	Product name
CR3045	1628838-42-5	RAF709 RAF709 is a potent inhibitor of B/C RAF kinase with almost equivalent IC50 values of 0.4 nM for B-RAF and C-RAF, showing a hig..
CR3044	345630-40-2	SF1670 SF1670 is a specific phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor. SF1670 specifically binds to the ac..
CR3043	61350-00-3	VU0364770 VU0364770 is a Positive allosteric modulator at mGlu4 receptors (EC50 = 290 nM in mGlu4-expressing HEK 293 cells). VU0364770 produ..
CR3421	214470-68-5	Bosutinib Intermediates Synonyms: 7-(3-chloro-propoxy)-4-chloro-6-methoxy-quinoline-3-carbonitrile;4-chloro-7-[3-chloropropoxy]-3-cyano-6-methoxyquinoline..
CR3420	1435934-25-0	A 419259 trihydrochloride A 419259 trihydrochloride is a Src family kinases inhibitor with IC50s of 9 nM, 3 nM and 3 nM for Src, Lck and Lyn, ..
CR3042	1207253-08-4	MK-1064 MK-1064 is a potent, selective and orally active Orexin OX2 Receptor Antagonist for potential treatment of insomnia. Preclinically..
CR3041	1613028-81-1	SR9243 SR9243 is a potent and selective LXR inverse agonist. SR9243 kills cancer cells by inhibiting lipid production and the Warburg eff..
CR3040	1234563-16-6	GSK2251052 Epetraborole hydrochloride Epetraborole hydrochloride is a novel leucyl-tRNA synthetase (LeuRS) inhibitor, which inhibits protein synthesis by binding "..
CR3039	1093643-37-8	GSK2251052 Epetraborole Epetraborole, also known as GSK2251052 and AN3365, is a potent and selective leucyl-tRNA synthetase inhibitor. Epetraborole was in..
CR3038	1025967-78-5	SAR1118 Lifitegrast Lifitegrast, also known as SAR-1118, is an LFA-1 antagonist intended for the treatment of vascular complications of the eye. Lifit..

首页上一页当前第75/295页共2950条记录每页10条73 747576 77 下一页尾页